Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-13 4:55 pm Purchase | 13G | MERCK & CO INC MRK | VANGUARD GROUP INC | 244,767,034 9.66% | 17,561,056 (+7.73%) | View |
| 2024-01-26 11:49 am Sale | 13G | MERCK & CO INC MRK | BlackRock Inc. BLK | 201,836,434 8% | -13,174,951 (-6.13%) | View |
| 2024-01-23 3:29 pm Purchase | 13G | EVAXION BIOTECH A/S ADS EVAX | Merck & Co. Inc. MRK | 4,595,588 11.4% | 4,595,588 (New Position) | View |
| 2023-02-09 10:54 am Purchase | 13G | MERCK & CO INC MRK | VANGUARD GROUP INC | 227,205,978 8.96% | 16,003,447 (+7.58%) | View |
| 2023-02-03 4:27 pm Purchase | 13G | MERCK & CO INC MRK | BlackRock Inc. BLK | 215,011,385 8.5% | 16,787,121 (+8.47%) | View |
| 2022-02-09 3:15 pm Purchase | 13G | MERCK & CO INC MRK | VANGUARD GROUP INC | 211,202,531 8.36% | 2,791,887 (+1.34%) | View |
| 2022-02-02 5:21 pm Purchase | 13G | 4D PHARMA PLC SPONSORED ADS LBPS | Merck & Co. Inc. MRK | 12,145,523 6.6% | 12,145,523 (New Position) | View |
| 2022-01-31 5:59 pm Purchase | 13G | MERCK & CO INC MRK | BlackRock Inc. BLK | 198,224,264 7.8% | 2,010,460 (+1.02%) | View |
| 2021-03-04 06:06 am Purchase | 13D | PANDION THERAPEUTICS INC PAND | Merck & Co. Inc. MRK | 11,776,706 39.99% | 11,776,706 (New Position) | View |
| 2021-02-10 10:02 am Sale | 13G | MERCK & CO INC MRK | VANGUARD GROUP INC | 208,410,644 8.24% | -2,131,689 (-1.01%) | View |
| 2021-02-05 08:03 am Purchase | 13G | MERCK & CO INC MRK | BlackRock Inc. BLK | 196,213,804 7.8% | 5,430,579 (+2.85%) | View |
| 2021-01-04 2:28 pm Purchase | 13G | YUMANITY THERAPEUTICS INC YMTX | Merck & Co. Inc. MRK | 526,999 5.2% | 526,999 (New Position) | View |
| 2020-02-12 09:23 am Purchase | 13G | MERCK & CO INC MRK | VANGUARD GROUP INC | 210,542,333 8.26% | 4,948,744 (+2.41%) | View |
| 2020-02-05 12:15 pm Sale | 13G | MERCK & CO INC MRK | BlackRock Inc. BLK | 190,783,225 7.5% | -3,806,316 (-1.96%) | View |
| 2019-12-16 5:12 pm Purchase | 13D | ARQULE INC ARQL | Merck & Co. Inc. MRK | 17,481,903 12.6% | 17,481,903 (New Position) | View |